Tofacitinib Devatis 5 mg

Tofacitinib Devatis 5 mg is a medicine authorised by Swissmedic under authorisation number 69213. The authorisation holder is Devatis AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 19 June 2025 and the authorisation is limited until 18 June 2030. ATC code L04AF01 places the medicine in the group Immunosuppressants.

  • Dispensing category B
  • Authorisation number 69213
  • ATC L04AF01
  • Synthetic medicines
Authorisation data
Authorisation number69213
NameTofacitinib Devatis 5 mg
Full nameTofacitinib Devatis 5 mg, Filmtabletten
Authorisation holderDevatis AG
Medicinal product codeSynthetic medicines
Dispensing categoryB · Prescription only
ATC codeL04AF01
First authorisation19 June 2025
Authorisation validity18 June 2030
Strengths
No.NameDispensing categoryAuthorisation date
1Tofacitinib Devatis 5 mg, FilmtablettenB19 June 2025
2Tofacitinib Devatis 10 mg, FilmtablettenB19 June 2025

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
156Tablette(n)L04AF0107.15.0.B
256Tablette(n)L04AF0107.15.0.B

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Tofacitinib Devatis 5 mg authorised in Switzerland?

Yes. Tofacitinib Devatis 5 mg is authorised by Swissmedic under authorisation number 69213, data as of 01 September 2026. The authorisation is limited until 18 June 2030.

Which dispensing category does Tofacitinib Devatis 5 mg have?

Tofacitinib Devatis 5 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Tofacitinib Devatis 5 mg?

The authorisation holder is Devatis AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com